Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Timothy J, Wilkin"'
Autor:
Eva M. Stevenson, Sandra Terry, Dennis Copertino, Louise Leyre, Ali Danesh, Jared Weiler, Adam R. Ward, Pragya Khadka, Evan McNeil, Kevin Bernard, Itzayana G. Miller, Grant B. Ellsworth, Carrie D. Johnston, Eli J. Finkelsztein, Paul Zumbo, Doron Betel, Friederike Dündar, Maggie C. Duncan, Hope R. Lapointe, Sarah Speckmaier, Nadia Moran-Garcia, Michelle Premazzi Papa, Samuel Nicholes, Carissa J. Stover, Rebecca M. Lynch, Marina Caskey, Christian Gaebler, Tae-Wook Chun, Alberto Bosque, Timothy J. Wilkin, Guinevere Q. Lee, Zabrina L. Brumme, R. Brad Jones
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
Here, the authors show in a cohort of people with HIV, COVID mRNA vaccination is followed by a transient boost in a particular profile of HIV-specific T-cell responses and a corresponding decrease in residual HIV RNA – suggesting productive immune
Externí odkaz:
https://doaj.org/article/d9cd2a88e3f64b5bb298b5bf37dbca63
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
Gay, bisexual, and other men who have sex with men (MSM) and transgender women, particularly those who are living with HIV, are disproportionately affected by human papillomavirus (HPV). For this narrative review of HPV health outcomes and vaccinatio
Externí odkaz:
https://doaj.org/article/3eb38a0af94541db89bf99cd17ffcc56
Autor:
Roy M. Gulick, Rodrigo R.R. Duarte, Dennis C Copertino, Miguel de Mulder Rougvie, Timothy R. Powell, Timothy J. Wilkin, Bruno C Casado Lima, Christopher E. Ormsby, Douglas F. Nixon
Publikováno v:
Journal of biomolecular structuredynamics. 40(16)
COVID-19 is the disease caused by SARS-CoV-2 which has led to 2,643,000 deaths worldwide, a number which is rapidly increasing. Urgent studies to identify new antiviral drugs, repurpose existing drugs, or identify drugs that can target the overactive
Autor:
Zizipho Z.A. Mbulawa, Timothy J. Wilkin, Bridgette Goeieman, Avril Swarts, Sophie Williams, Simon Levin, Mark Faesen, Jennifer S. Smith, Carla J. Chibwesha, Anna-Lise Williamson, Cynthia Firnhaber
Publikováno v:
Papillomavirus Research, Vol 2, Iss , Pp 56-60 (2016)
This study investigated the performance of Cepheid Xpert human papillomavirus (HPV) assay in South African human immunodeficiency virus (HIV)-infected women and compared its performance with that of hybrid capture-2 (hc2). Methods: Stored cervical sp
Externí odkaz:
https://doaj.org/article/b742c6a92fa544b281845d4f2b287538
Autor:
Thomas M. Atkinson, Shelly Lensing, Jeannette Y. Lee, Di Chang, Soo Young Kim, Yuelin Li, Kathleen A. Lynch, Andrew Webb, Susan M. Holland, Erica I. Lubetkin, Stephen Goldstone, Mark H. Einstein, Elizabeth A. Stier, Dorothy J. Wiley, Ronald Mitsuyasu, Isabella Rosa-Cunha, David M. Aboulafia, Shireesha Dhanireddy, Jeffrey T. Schouten, Rebecca Levine, Edward Gardner, Jeffrey Logan, Hillary Dunleavy, Luis F. Barroso, Gary Bucher, Jessica Korman, Benjamin Stearn, Timothy J. Wilkin, Grant Ellsworth, Julia C. Pugliese, Abigail Arons, Jack E. Burkhalter, David Cella, J. Michael Berry-Lawhorn, Joel M. Palefsky
Publikováno v:
Quality of Life Research.
Autor:
Thomas M. Atkinson, PhD, Joel Palefsky, MD, J. Michael Berry, MD, Stephen Goldstone, MD, Andrew Webb, Rebecca Levine, MD, Timothy J. Wilkin, MD, MPH, Gary Bucher, MD, David Cella, PhD, Jeannette Lee, PhD, Jeff Taylor, Yuelin Li, PhD, Jack Burkhalter, PhD
Publikováno v:
Papillomavirus Research, Vol 5, Iss , Pp S1-S2 (2018)
Background: Precancerous anal high-grade squamous intraepithelial lesions (HSIL) and its associated treatments have the potential to reduce health-related quality of life (HRQoL) in impacted individuals. The ANCHOR (ANal Cancer HSIL Outcomes Research
Externí odkaz:
https://doaj.org/article/c15e3e2a9e284cbaa4fc4c5cc729aec0
Autor:
Shashi N Kapadia, Chunyuan Wu, Kenneth H Mayer, Timothy J Wilkin, K Rivet Amico, Raphael J Landovitz, Adriana Andrade, Ying Q Chen, Wairimu Chege, Marybeth McCauley, Roy M Gulick, Bruce R Schackman
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0206577 (2018)
IntroductionTenofovir (TDF)-containing PrEP is effective for HIV prevention, but its effect on health-related quality of life (QOL) is unknown. Using data from HPTN 069/ACTG A5305, a randomized study of potential PrEP regimens comparing maraviroc alo
Externí odkaz:
https://doaj.org/article/ddc445f3d6e34e8ebfae890f8d028c6e
Autor:
Johannes S Gach, Andrea Gorlani, Emmanuel Y Dotsey, Juan C Becerra, Chase T M Anderson, Baiba Berzins, Philip L Felgner, Donald N Forthal, Steven G Deeks, Timothy J Wilkin, Joseph P Casazza, Richard A Koup, Christine Katlama, Brigitte Autran, Robert L Murphy, Chad J Achenbach
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160341 (2016)
Little is known about the humoral immune response against DNA prime-recombinant adenovirus 5 (rAd5) boost HIV vaccine among HIV-infected patients on long-term suppressive antiretroviral therapy (ART). Previous studies emphasized cellular immune respo
Externí odkaz:
https://doaj.org/article/05060ed186404214b00da813729017ee
Autor:
Victoria Umutoni, Matthew B. Schabath, Alan G. Nyitray, Timothy J. Wilkin, Luisa L. Villa, Eduardo Lazcano-Ponce, Anna R. Giuliano, Staci L. Sudenga
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background:Previous studies show an association between smoking and anal cancer. The objective of this study was to assess the association between smoking and anal HPV (human papillomavirus) prevalence, incidence, and persistence in men.Methods:The H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57e310d8e7488411ab07572667486fa1
https://doi.org/10.1101/2021.10.18.21265161
https://doi.org/10.1101/2021.10.18.21265161
Publikováno v:
Top Antivir Med
The 2021 Conference on Retroviruses and Opportunistic Infections included advances in therapy for HIV as well as for SARS-CoV-2. Data presented on COVID-19 therapies included trials showcasing the use of monoclonal antibodies for prevention and treat